Drug Delivery Across Blood Brain Barrier Market - Forecast(2022 - 2027)

Report Code: HCR 1423 Report Format: PDF + Excel

Drug Delivery Across Blood Brain Barrier Market Overview

Drug Delivery across Blood Brain Barrier Market size is estimated to reach $ 4,627.3 million by 2026, growing at a CAGR of 5% over 2021-2026. The blood brain barrier helps to protect the brain from harmful chemicals and maintains a constant environment. The blood brain barrier is a kind of protecting structure that provides a control on passage that moving from blood to the tissues of the central nervous system. Liposomes are an important tool to transfer drugs across the blood brain carrier owing to their flexible properties. The blood brain barrier are formed by the brain microvascular endothelial cells, a central element of the microvasculature that guard the brain against toxins. Growing incidence of neurological disorders and rising technological advancements is the major factor driving the growth of this market. Furthermore, rising prevalence of dementia and development in magnetic resonance imaging helps to detect blood brain barrier that can predict stroke patient’s is set to further enhance the overall market demand for Drug Delivery across Blood Brain Barrier Market for the period 2021-2026. 

Report Coverage

The report: “Drug Delivery across Blood Brain Barrier Market Forecast (2021-2026)”, by IndustryARC, covers an in-depth analysis of the following segments of the Drug Delivery across Blood Brain Barrier Market.
By Technology: Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing Permeability, Passive Diffusion, Others
By Application: Alzheimer’s Disease, Epilepsy, Parkinson’s Disease, Multiple Sclerosis, Hunter’s Syndrome, Brain Cancer, Others.
By Geography: North America (U.S., Canada, Mexico), South America (Brazil, Argentina, Others) Europe (U.K, Germany, Italy, France, Spain, Russia, Rest of Europe), Asia Pacific (China, Australia, Japan, South Korea, India, Rest of Asia Pacific) and Rest of the World (Middle East, Africa).

Key Takeaways

  • Geographically, in 2020 North America dominated the Drug Delivery across Blood Brain Barrier Market owing to increasing adoption of advanced technology for treating severe life-threatening disorders, rising prevalence of hunter’s and alzheimer’s syndrome.
  • Growing incidence of neurological disorders and rising technological advancements are likely to aid in the market growth of the Drug Delivery across Blood Brain Barrier.
  • Detailed analysis of the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Drug Delivery across Blood Brain Barrier Market report.
  • Leakage in blood brain barrier is set to create hurdles for the Drug Delivery across Blood Brain Barrier Market.

Drug Delivery Across Blood Brain Barrier Market Segment Analysis - By Technology

The global Drug Delivery across Blood Brain Barrier Market based on Technology can be further segmented into Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing Permeability, Passive Diffusion, Others. The Increasing Permeability of blood brain barrier segment is the major segment generating revenue in 2020. This is owing to rising number of research activities for the treatment of various neurological and CNS (Central Nervous System) Disorders. The Trojan Horse Approach segment is estimated to register the fastest CAGR of 3.8% for the period 2021-2026. This is owing to increasing demand of biologics for treating brain disorders. Biologics are also considered as a new therapy for treating most CNS (Central Nervous System) disorders.

Drug Delivery across Blood Brain Barrier Market Size, By Technology 2020-2026 (USD Million)

Drug Delivery Across Blood Brain Barrier Market Segment Analysis - By Application

The global Drug Delivery across Blood Brain Barrier Market based on Application can be further segmented into Alzheimer’s Disease, Epilepsy, Parkinson’s Disease, Multiple Sclerosis, Hunter’s Syndrome, Brain Cancer, Others. The Parkinson’s Disease segment registers for the highest market share in 2020. According to National institute on Aging, in 2020 about 5-10% of people have parkinson’s at the age of 50 and are mostly occur in men. The Epilepsy segment is estimated to register the fastest CAGR of 1.2% over 2021-2026. According to World Health Organization in 2019, about 50 million people are affected by epilepsy which increases the growth of this segment.

Drug Delivery Across Blood Brain Barrier Market Segment Analysis - By Geography

North America dominated the Drug Delivery across Blood Brain Barrier Market with major share of 45% in 2020. This is owing to increasing adoption of advanced technology for treating severe life-threatening disorders, rising prevalence of Hunter’s and Azheimer’s syndrome. According to National Institute of Health, about 5.5 million Americans are suffering from Alzheimer’s in 2020 which are contributing to the rise in market growth.

However, Asia-Pacific is estimated to outpace all the regions by clocking the highest CAGR of 20% during the forecast period 2021-2026 owing to the increasing geriatric population and improving innovative technologies. 

Drug Delivery across Blood Brain Barrier Market Drivers

Growing Incidence of Neurological Disorders

The increasing prevalence of neurological diseases such as meningitis, multiple sclerosis, Parkinson’s disease, and encephalitis, growing geriatric population increases the growth of the Drug Delivery across Blood Brain Barrier Market. Moreover, rising demand for treatment and rise in the innovations helps safe and reliable transmission of medication. Thus, increasing the growth of the Drug Delivery across Blood Brain Barrier Market over 2021-2026. 

Rising Technological Advancement

Growing technological advancement and rising healthcare sector is increasing the growth of the Drug Delivery across Blood Brain Barrier Market. Moreover, increasing use of nanotechnology in treating various medical conditions and rising development in magnetic resonance imaging increases the growth of Drug Delivery across Blood Brain Barrier Market over 2021-2026. 

Covid-19 Impact:

COVID-19 is adversely impact the growth of Drug Delivery across Blood Brain Barrier Market. Moreover, recent clinical studies believed that people suffering from Central Nervous System complications are more susceptible to COVID-19 infection owing to low immunity that positively affected the growth of Drug Delivery across Blood Brain Barrier Market. 

Drug Delivery across Blood Brain Barrier Market Challenges

Leakage in Blood Brain Barrier

The factors that is set to impede the growth of the Drug Delivery across Blood Brain Barrier Market are the rising risk in leakage of blood brain barrier that can enter harmful substances. Moreover, it takes out all the nutrients is set to create hurdles for the Drug Delivery across Blood Brain Barrier Market. 

Drug Delivery across Blood Brain Barrier Industry Outlook

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Drug Delivery across Blood Brain Barrier Market. Key companies of this market include Ossianix, Inc., Amneal Pharmaceuticals Inc., Insightec, Angiochem Inc., Armagen Technologies, Inc., BrainsGate, BiOasis Technologies, Inc., CarThera, F. Hoffman La-Roche, and Iproteos S.L. 

Acquisitions/Product Launches

  • In November 2019, SK Biopharmaceuticals launches an anti-epileptic drug XCOPRI which also receives FDA approval.

Relevant Reports:

Report Code: HCR 0300
Report Code: HCR 0064

For more Lifesciences and Healthcare Market reports, Please Click here
1. Drug Delivery across Blood Brain Barrier Market Overview
    1.1 Definitions and Scope
2. Drug Delivery across Blood Brain Barrier Market Executive Summary
    2.1 Market Size and Key Trends
    2.2 Key trends by Technology
    2.3 Key trends by Application
    2.4 Key trends by Geography
3. Drug Delivery across Blood Brain Barrier Market Landscape
    3.1 Market Share Analysis- Key Companies
    3.2 Product Benchmarking- Key Companies
    3.3 Financial Analysis - Key Companies
    3.4 Patent Analysis
    3.5 Pricing Analysis
4. Drug Delivery across Blood Brain Barrier Market- Startup companies Scenario Premium Premium
    4.1 Key startup company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Drug Delivery across Blood Brain Barrier Market- Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of successful ventures
6. Drug Delivery across Blood Brain Barrier Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters Five Force Model
        6.3.1 Bargaining Power of Suppliers
        6.3.2 Bargaining Powers of Customers
        6.3.3 Threat of New Entrants
        6.3.4 Rivalry Among Existing Players
        6.3.5 Threat of Substitutes
7. Drug Delivery across Blood Brain Barrier Market Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Drug Delivery across Blood Brain Barrier Market– By Technology (Market Size -$Million/$Billion)
    8.1 Trojan Horse Approach
    8.2 Bispecific Antibody RMT Approach
    8.3 Increasing Permeability
    8.4 Passive Diffusion
    8.5 Others
9. Drug Delivery across Blood Brain Barrier Market– By Application (Market Size -$Million/$Billion)
    9.1 Alzheimer’s Disease
    9.2 Epilepsy
    9.3 Parkinson’s Disease
    9.4 Multiple Sclerosis
    9.5 Hunter’s Syndrome
    9.6 Brain Cancer
    9.7 Others
10. Drug Delivery across Blood Brain Barrier Market- By Geography (Market Size -$Million/$Billion)
    10.1 North America
        10.1.1 U.S.
        10.1.2 Canada
        10.1.3 Mexico
    10.2 South America
        10.2.1 Brazil
        10.2.2 Argentina
        10.2.3 Others
    10.3 Europe
        10.3.1 U.K.
        10.3.2 Germany
        10.3.3 Italy
        10.3.4 France
        10.3.5 Spain
        10.3.6 Russia
        10.3.7 Rest of Europe
    10.4 Asia-Pacific
        10.4.1 China
        10.4.2 Australia
        10.4.3 Japan
        10.4.4 South Korea
        10.4.5 India
        10.4.6 Rest of Asia-Pacific
    10.5 Rest of the World
        10.5.1 Middle East
        10.5.2 Africa
11. Drug Delivery across Blood Brain Barrier Market Entropy
12. Drug Delivery across Blood Brain Barrier Market- Industry / Segment Competition landscape Premium Premium
    12.1 Market Share Analysis
        12.1.1 Market Share by Country- Key companies
        12.1.2 Market Share by Region- Key companies
        12.1.3 Market Share at Global Level- Key companies
        12.1.4 Best Practices for Companies
13. Drug Delivery across Blood Brain Barrier Market- Key Company List by Country Premium Premium
14. Drug Delivery across Blood Brain Barrier Market Company Analysis
    14.1 Company Revenue, Products, M&A, Developments
    14.2 Company 1
    14.3 Company 2
    14.4 Company 3
    14.5 Company 4
    14.6 Company 5
    14.7 Company 6
    14.8 Company 7
    14.9 Company 8
    14.10 Company 9
    14.11 Company 10
"*Financials for private companies would be provided on a best efforts basis”